Family physicians’ journal repudiates morning-sickness guidelineControversial drug Diclectin no longer considered first-line treatment Fluoroquinolones can cause rare serious, persistent and disabling adverse effectsHealth Canada strengthens fluoroquinolone warnings and provides advice to healthcare professionals and the public. Health Canada seizes 'health products' from Toronto adult shop Dangerous 'poppers', sexual enhancement products seized. Surviving cuts, shaking off despair, and embracing opportunity Health Canada approves app-enabled Contour Next One blood glucose monitoring system Provides blood glucose reading accuracy to within 8.4% of lab readings. Canada's second private plasma clinic may open this spring Stelara: first interleukin inhibitor approved for use in Crohn’s disease New intravenous solution for single-dose induction, followed by subcutaneous maintenance therapy. Montreal hospital first to use new coronary device invented in Toronto CPhA applauds pot task force report Document says government should be open to pharmacy distribution of medicinal cannabis if legalizing recreational use compromises access. Chlorpropamide to be discontinued in Canada before mid-2017 Patients taking chlorpropamide must be switched to an alternate therapy for type 2 diabetes. First Previous 153 154 155 156 157 Next Last
